Therapy News and Research

RSS

Researchers review potential of targeted nanocarriers to revolutionize cancer care

A new Tel Aviv University study addresses the challenges of nanoparticle-based cancer-targeting strategies. It also suggests ways of refocusing the collaborative work of cancer researchers and clinicians to move the field forward from "the bench" to the patients.

12 Apr 2018

UCLA scientists identify four subtypes of melanoma with different drug sensitivities

Melanoma, a relatively rare but deadly skin cancer, has been shown to switch differentiation states - that is, to regress to an earlier stage of development - which can lead it to become resistant to treatment.

12 Apr 2018

Dietary fats play varied roles in disease

This month's issue of the Journal of Lipid Research features studies examining how fats in the diet affect health, including whether the ketogenic diet is a reasonable cancer therapy; how the type of unsaturated fats in a mouse's chow affects inflammation; and how cells respond to nutrient signals.

12 Apr 2018

FDA approves marketing of AI device to detect diabetic retinopathy

The U.S. Food and Drug Administration yesterday (11th of April 2018), released a statement approving the marketing of world’s first artificial intelligence using medical device that can detect diabetic retinopathy among diabetic patients.

12 Apr 2018

Study explores relationship between age at menopause and memory

Entering menopause at a later age may be associated with a small benefit to your memory years later, according to a study published in the April 11, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.

12 Apr 2018

ESMO: New system to rank relevance of treatable cancer genetic mutations needed

ESMO, the leading professional organization for medical oncology, welcomes the latest reports from The Cancer Genome Atla as a major resource for researchers across the world and calls for increased across-the-board commitment to translate these efforts into medical advances for the benefit of cancer patients.

11 Apr 2018

Ludwig scientists develop and test individualized ovarian cancer vaccine

A Ludwig Cancer Research study has shown that an entirely new type of personalized cancer vaccine induces novel, potent and clinically effective immune responses in patients receiving a combination of standard therapies for recurrent, stage III and IV ovarian cancer.

11 Apr 2018

Study offers new hope for patients with intrahepatic cholangiocarcinoma

Kandice Fogle, 43, had just moved to Houston when she began experiencing pain in her back and groin. After undergoing a CT scan, doctors found a large mass in her liver. A biopsy confirmed that she had intrahepatic cholangiocarcinoma, more commonly known as bile duct cancer.

11 Apr 2018

Short international trips can lead to spread of colistin resistance

The emergence of antibiotic resistance among dangerous pathogens is increasingly problematic worldwide. Many strains of infectious bacteria have become multidrug-resistant, and cannot be treated with common antibiotic therapies.

11 Apr 2018

Nasal vaccine may suppress peanut allergy in mice, study shows

A vaccine may successfully turn off peanut allergy in mice, a new study shows.Just three monthly doses of a nasal vaccine protected the mice from allergic reactions upon exposure to peanut, according to research from the Mary H. Weiser Food Allergy Center at the University of Michigan.

11 Apr 2018

Vascular dysfunction associated with severe menopausal symptoms

Heart disease remains the leading cause of death in women. A study of 138 menopausal women examined the association of mood, symptoms, and quality of life measures with the key markers of vascular aging, a major risk factor for the development of cardiovascular disease (CVD)

11 Apr 2018

Biomarker panel can guide future therapeutic decisions for glioma patients

In an article published April 10th in the journal Cell Reports, researchers at the University of São Paulo describe a biomarker panel that could tell physicians which patients diagnosed with glioma, a type of brain cancer, will tend to progress to a more aggressive form of the disease in the event of relapse.

10 Apr 2018

Data-driven tool defines risk stages for children with chronic kidney disease

Experts in pediatric kidney disease have published a new staging system to help doctors better predict the length of time until a child with chronic kidney disease (CKD) will need to undergo a kidney transplant or start receiving dialysis. Although this type of prognostic guide exists for adults, this is the first such tool specific to children.

10 Apr 2018

Scientists find new molecular target to treat idiopathic pulmonary fibrosis

Scientists searching for a therapy to stop the deadly and mostly untreatable lung disease, idiopathic pulmonary fibrosis (IPF), found a new molecular target that slows or stops the illness in preclinical laboratory tests.

10 Apr 2018

Japanese researchers develop new compound to enhance recovery of stroke patients

A team of Japanese researchers have developed a new compound that enhanced motor function recovery after brain damage in animal tests, according to a study published in the journal Science.

10 Apr 2018

New system promises greater accuracy in determining heart transplant rejection and injury

The results of an international clinical trial for a new system of diagnosing heart transplant rejection and injury will be presented publicly for the first time at the International Society for Heart & Lung Transplantation annual meeting, which will take place on April 11 and 12 in Nice, France.

10 Apr 2018

Researchers suggest alternative therapy for heart attack patients with beta blocker intolerance

Beta blockers have become a prescription drug staple for recovering heart attack patients. However, these blood pressure-reducing medications cannot be tolerated by many patients who are at higher risk for developing cardiovascular disease, including those with chronic obstructive pulmonary disease and asthma, the elderly, and diabetics.

10 Apr 2018

Early intervention needed to help breast cancer patients manage 'chemobrain' symptoms

More support is needed to help breast cancer patients and survivors manage 'chemobrain' symptoms, such as memory loss, short attention span and mental confusion, according to a study led by researchers from the National University of Singapore.

10 Apr 2018

Tradeshow Talks with Synthace

Sean Ward, CTO of Synthace, tells us why they are at Analytica 2018.

10 Apr 2018

Heart disease risk in breast cancer patients after treatment not higher than average population

Many breast cancer therapies cause damage to the heart. However, in the largest study of its kind so far, scientists from the German Cancer Research Center in Heidelberg have now shown that the risk of death from heart disease in breast cancer patients following radiotherapy or chemotherapy is no higher than it is among the average population.

9 Apr 2018

Therapy News and Research

Researchers review potential of targeted nanocarriers to revolutionize cancer care

UCLA scientists identify four subtypes of melanoma with different drug sensitivities

Dietary fats play varied roles in disease

FDA approves marketing of AI device to detect diabetic retinopathy

Study explores relationship between age at menopause and memory

ESMO: New system to rank relevance of treatable cancer genetic mutations needed

Ludwig scientists develop and test individualized ovarian cancer vaccine

Study offers new hope for patients with intrahepatic cholangiocarcinoma

Short international trips can lead to spread of colistin resistance

Nasal vaccine may suppress peanut allergy in mice, study shows

Vascular dysfunction associated with severe menopausal symptoms

Biomarker panel can guide future therapeutic decisions for glioma patients

Data-driven tool defines risk stages for children with chronic kidney disease

Scientists find new molecular target to treat idiopathic pulmonary fibrosis

Japanese researchers develop new compound to enhance recovery of stroke patients

New system promises greater accuracy in determining heart transplant rejection and injury

Researchers suggest alternative therapy for heart attack patients with beta blocker intolerance

Early intervention needed to help breast cancer patients manage 'chemobrain' symptoms

Tradeshow Talks with Synthace

Heart disease risk in breast cancer patients after treatment not higher than average population

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News